Back

FIDELITY Analysis: finerenone in mild-to-severe chronic kidney disease and type 2 diabetes - Part 1

28 August 2021 (17:42 - 17:46)
Organised by:
Congress Presentation Part of: Hot Line - FIGARO-DKD / FIDELITY Analysis Pharmacology and Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

5 More presentations in this session

Presentation thumbnail
FIGARO-DKD: finerenone in patients with chronic kidney disease and type 2 diabetes
Professor B. Pitt (Ann Arbor, US)
Slides Video
Presentation thumbnail
FIGARO-DKD - Discussant review.
Associate Professor K. Damman (Groningen, NL)
Slides Video
Presentation thumbnail
FIDELITY Analysis: finerenone in mild-to-severe chronic kidney disease and type 2 diabetes
Professor G. Filippatos (Athens, GR)
Slides Video
Presentation thumbnail
FIDELITY Analysis - Discussant review.
Professor C. Baigent (Oxford, GB)
Slides Video
Presentation thumbnail
FIGARO-DKD / FIDELITY Analysis - Panel discussion.

Access the full session

Session thumbnail
Hot Line - FIGARO-DKD / FIDELITY Analysis
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 17:42 CET
You may be interested in
thumbnail
Congress Session
Challenges in hypertension management
thumbnail
Congress Presentation
Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension
thumbnail
Congress Session
Optimal management of chronic coronary syndromes: putting the evidence into practice

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources